vVARDIS Achieves Unicorn Status with Investment from Apollo
vVARDIS Holding AG, a dental medtech company specializing in non-invasive cavity treatment, has received a strategic minority investment from Apollo-managed funds. This investment aims to facilitate the company’s global growth and commercial expansion, particularly in the rollout of its Curodont™ product suite, and marks vVARDIS as a unicorn, valued at over one billion dollars.
ZUG, Switzerland–(BUSINESS WIRE)–vVARDIS Holding AG (“vVARDIS”), a high-growth dental medtech company pioneering non-invasive cavity treatment, today announced a strategic minority investment from Apollo-managed funds (“Apollo Funds”). The investment will support vVARDIS’ next phase of global growth and commercial expansion, including the continued rollout of its Curodont™ suite of products. The investment establishes vVARDIS as one of Europe’s few privately owned, billion-dollar-plus, health